SHINEWAY PHARM 02877·

Gross margin ------------------------------------------------------------74.77%--74.38%0.40%75.15%0.77%74.95%0.20%72.28%2.68% Net margin ------------------------------------------------------------17.27%--18.30%1.03%21.47%3.17%22.24%0.77%30.30%8.06% ROE ------------------------------------------------------------9.43%--11.32%1.89%13.78%2.46%11.25%2.53%11.78%0.53% ROA ------------------------------------------------------------7.73%--8.78%1.05%10.13%1.35%8.37%1.76%8.81%0.45% Revenue growth ----------------------------------------------------------------22.56%--14.32%8.23%-16.35%30.68%-17.01%0.66% Attributable profit growth ----------------------------------------------------------------29.84%--34.14%4.30%-13.35%47.49%13.08%26.43% Debt-to-assets ------------------------------------------------------------18.08%--22.47%4.39%26.52%4.06%25.64%0.88%25.20%0.44% Current ratio ------------------------------------------------------------5.19--4.071.123.350.723.510.163.710.20 Operating cash flow / net profit ------------------------------------------------------------1.26--1.540.270.960.571.150.181.230.09 Operating cash flow / revenue ------------------------------------------------------------21.81%--28.09%6.28%20.65%7.44%25.49%4.84%37.38%11.89%

Gross margin 72.22%--69.90%2.32% Net margin 37.19%--39.72%2.53% Revenue growth -----28.54%-- Attributable profit growth -----23.67%-- Current ratio ----4.32--

Revenue ------------------------------------------------------------3.22B--3.95B22.56%4.52B14.32%3.78B16.35%3.14B17.01% Other income and gains ------------------------------------------------------------206.37M--212.47M2.96%268.63M26.44%371.78M38.40%571.56M53.74% Gross profit ------------------------------------------------------------2.41B--2.94B21.90%3.39B15.51%2.83B16.57%2.27B19.97% Selling and distribution expenses ------------------------------------------------------------1.50B--1.82B21.27%1.98B8.96%1.60B19.39%1.17B27.03% Administrative expenses ------------------------------------------------------------256.56M--279.80M9.06%326.50M16.69%291.32M10.77%279.69M3.99% Net finance costs ------------------------------------------------------------1.25M--630.00K49.76%2.74M334.44%6.13M123.93%5.68M7.24% Income tax ------------------------------------------------------------163.43M--194.25M18.86%270.74M39.38%305.67M12.90%319.32M4.47% Operating profit ------------------------------------------------------------721.36M--917.65M27.21%1.24B35.45%1.15B7.33%1.27B10.69% Profit before tax ------------------------------------------------------------720.10M--917.02M27.35%1.24B35.25%1.15B7.62%1.27B10.78% Net profit ------------------------------------------------------------556.67M--722.77M29.84%969.51M34.14%840.05M13.35%949.95M13.08% Net profit attributable to owners ------------------------------------------------------------556.67M--722.77M29.84%969.51M34.14%840.05M13.35%949.95M13.08%

Revenue 1.65B--1.18B28.54% Other income and gains 162.06M--128.84M20.50% Cost of sales 459.09M--355.47M22.57% Gross profit 1.19B--825.62M30.83% Selling and distribution expenses 647.84M--312.24M51.80% Administrative expenses 126.45M--106.85M15.50% Net finance costs 5.86M--2.21M62.30% Income tax 160.01M--99.15M38.04% Profit before tax 774.68M--568.31M26.64% Net profit 614.66M--469.16M23.67% Net profit attributable to owners 614.66M--469.16M23.67%

Cash and cash equivalents --------------------------------------------------------------------5.89B--6.14B4.27%7.19B17.08% Trade and bills receivables ------------------------------------------------------------825.18M--975.06M18.16%1.26B29.26%1.20B4.64%1.00B16.79% Inventories ------------------------------------------------------------587.96M--657.66M11.86%897.71M36.50%813.19M9.41%691.30M14.99% Total current assets ------------------------------------------------------------5.70B--6.78B19.01%8.15B20.23%8.60B5.44%9.30B8.21% Total assets ------------------------------------------------------------7.20B--8.23B14.27%9.57B16.30%10.04B4.88%10.78B7.33% Total current liabilities ------------------------------------------------------------1.10B--1.67B51.64%2.43B46.12%2.45B0.67%2.51B2.46% Total liabilities ------------------------------------------------------------1.30B--1.85B41.99%2.54B37.30%2.57B1.39%2.72B5.46% Equity attributable to owners ------------------------------------------------------------5.90B--6.38B8.15%7.03B10.22%7.47B6.14%8.06B7.97% Total equity ------------------------------------------------------------5.90B--6.38B8.15%7.03B10.22%7.47B6.14%8.06B7.97%

Cash and cash equivalents ----7.54B-- Trade and bills receivables ----655.29M-- Inventories ----562.51M-- Total current assets ----9.01B-- Total assets ----8.37B-- Total current liabilities ----2.09B-- Equity attributable to owners ----8.21B-- Total equity ----8.21B--

Net cash from operating activities ------------------------------------------------------------703.15M--1.11B57.81%932.63M15.95%963.13M3.27%1.17B21.69% Net cash from investing activities ------------------------------------------------------------395.01M---45.42M111.50%-49.54M9.07%-272.11M449.27%222.03M181.60% Net cash from financing activities -------------------------------------------------------------828.93M---250.04M69.84%-26.74M89.31%-392.48M1367.85%-375.01M4.45% Net change in cash ------------------------------------------------------------269.23M--814.22M202.43%856.36M5.18%298.55M65.14%1.02B241.33%